Fosamax Mass Tort Update: Case Management Order Extends Three Core Discovery Dates, Parker Waichman LLP Announces

Share Article

The Case Management Order extends deadlines for the Tier II, III, and IV Femur Fracture Discovery Pools.

News Image

Parker Waichman LLP, a national law firm long dedicated to protecting the rights of victims who have been injured by defective drugs, reports that three core discovery deadlines in the Fosamax litigation have been extended based on a Case Management Order (CMO) filed on October 23, 2014. The case is In re: Fosamax Litigation, Superior Court of New Jersey, Law Division: Atlantic County, Case No. 282—L3632-08.

The CMOs, filed in Atlantic County Law Divisions, Superior Court of New Jersey, Law Division: Atlantic County extended the following core discovery deadlines:

  • Tier II Femur Fracture Discovery Pool: Extended to December 30, 2014
  • Tier III Femur Fracture Discovery Pool: Extended to December 30, 2014
  • Tier IV Femur Fracture Discovery Pool: Extended to February 27, 2015

Parker Waichman LLP has filed dozens of lawsuits on behalf of women who allegedly suffered Fosamax femur fractures following long-term use of the bisphosphonate medication. The lawsuits were filed in the Superior Court of New Jersey, Law Division, Atlantic County, where lawsuits involving alleged Fosamax side effects were designated a mass tort. Each of the complaints name Merck Sharp & Dohme Corporation (aka Merck & Company), Watson Pharmaceuticals, Inc., and Teva Pharmaceuticals USA as defendants and similarly allege that, as a direct and proximate result of the plaintiffs’ long-term use of Fosamax (alendronate sodium), they suffered severe mental and physical pain and suffering, among other claims. (In re: Fosamax Litigation [No. 282] NJ Superior Court)

Bisphosphonate drugs, such as Fosamax, received U.S. Food and Drug Administration (FDA) approval for the treatment of bone-weakening diseases like osteoporosis and Paget’s disease. Cancer patients also often undergo therapy with bisphosphonate drugs to prevent fractures from bone metastases, Parker Waichman notes.

Parker Waichman LLP continues to offer free legal consultations to victims of pharmaceutical and medical device side effects. If you or a loved experienced an injury as a result of a defective pharmaceutical or medical device, please contact the firm at 1 800 LAW INFO (1-800-529-4636).

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Gary Falkowitz
Follow us on
Visit website